Expression of drugable targets in pediatric malignancies: Innovative therapies for children with cancer

被引：0
|
作者：
Verschuur, A. C.
Versteeg, R.
Vassal, G.
Pieters, R.
Delattre, O.
Serra, M.
Pritchard-Jones, K.
Shipley, J.
Clifford, S.
Pietsch, T.
Geoerger, B.
Lanvers, C.
den Boer, M.
Caron, H.
机构：
[1] Emma Childrens Hosp AMC, Amsterdam, Netherlands
[2] Inst Gustave Roussy, F-94800 Villejuif, France
[3] Erasmus MC Sophia Childrens Hosp, Rotterdam, Netherlands
[4] Inst Curie, F-75005 Paris, France
[5] Inst Ortoped Rizzoli, Bologna, Italy
[6] Inst Canc Res, Sutton SM2 5NG, Surrey, England
[7] Univ Newcastle Upon Tyne, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England
[8] Univ Bonn, D-5300 Bonn, Germany
[9] Univ Klinikum Munster, Munster, Germany
来源：
ANNALS OF ONCOLOGY | 2007年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：28 / 28
页数：1
相关论文
共 50 条
  • [1] Targeting CTP synthetase in pediatric malignancies by the European consortium "Innovative Therapies for Children with Cancer"
    Verschuur, Ac
    Den Boer, Ml
    Vassal, G.
    Van Kuilenburg, Abp
    Versteeg, R.
    Serra, M.
    Serra, M.
    Lanvers, C.
    Delattre, O.
    Jones, K. Pritchard
    Shipley, J.
    Pietsch, T.
    Geoerger, B.
    Boos, J.
    Pieters, R.
    Caron, H. N.
    [J]. CANCER RESEARCH, 2006, 66 (08)
  • [2] Preclinical strategy for selecting novel compounds for pediatric malignancies: Innovative therapies for children with cancer
    Verschuur, A.
    [J]. EJC SUPPLEMENTS, 2006, 4 (12): : 77 - 77
  • [3] Preclinical evaluation of targets in pediatric malignancies for the selection of targeted compounds within the ITCC-consortium (innovative therapies for children with cancer)
    Verschuur, AC
    Den Boer, ML
    Vassal, G
    Caron, HN
    [J]. ANNALS OF ONCOLOGY, 2005, 16 : 35 - 35
  • [4] Preclinical target analyisis in pediatric malignancies for selecting targeted compounds: Innovative therapies for children with cancer.
    Verschuur, AC
    den Boer, ML
    Vassal, G
    Versteeg, R
    Serra, M
    Lanvers, C
    Delattre, O
    Jones, KP
    Shipley, J
    Clifford, S
    Pietsch, T
    Geoerger, B
    Pieters, R
    Caron, HN
    [J]. CLINICAL CANCER RESEARCH, 2005, 11 (24) : 9050S - 9050S
  • [5] Pediatric malignancies provide unique cancer therapy targets
    Üren, A
    Toretsky, JA
    [J]. CURRENT OPINION IN PEDIATRICS, 2005, 17 (01) : 14 - 19
  • [6] Emerging Role of Tyrosine Kinases as Drugable Targets in Cancer
    Na, Il-Kang
    le Coutre, Philipp
    [J]. BIOMARKER INSIGHTS, 2015, 10 : 29 - 31
  • [7] The Innovative Potential of Statins in Cancer: New Targets for New Therapies
    Di Bello, Elisabetta
    Zwergel, Clemens
    Mai, Antonello
    Valente, Sergio
    [J]. FRONTIERS IN CHEMISTRY, 2020, 8
  • [8] Pediatric Trials for Cancer Therapies With Targets Potentially Relevant to Pediatric Cancers
    Hwang, Thomas J.
    Orenstein, Liat
    DuBois, Steven G.
    Janeway, Katherine A.
    Bourgeois, Florence T.
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2020, 112 (03) : 224 - 228
  • [9] Vaccine therapies for pediatric malignancies
    Rousseau, RF
    Brenner, MK
    [J]. CANCER JOURNAL, 2005, 11 (04): : 331 - 339
  • [10] The UHRF family: Oncogenes that are drugable targets for cancer therapy in the near future?
    Bronner, Christian
    Achour, Mayada
    Arima, Yoshimi
    Chataigneau, Thierry
    Saya, Hideyuki
    Schini-Kerth, Valerie B.
    [J]. PHARMACOLOGY & THERAPEUTICS, 2007, 115 (03) : 419 - 434
12345